REZYFi is positioned as the first cannabis mortgage banker in the United States. With most traditional lenders reticent to serve the state-licensed cannabis industry, REZYFi stands distinct. “REZYFi services the needs of both traditional and non-traditional consumers and businesses. The company is targeting markets that include licensed and permitted cannabis companies, owners of real estate who lease to cannabis companies, and companies and individual homeowners seeking a variety of real estate-related first and additional mortgage-based financing and project-specific financings, such as solar installations and real estate development projects,” a recent article reads. “REZYFi operates under two wholly owned subsidiaries – REZYFi Lending and ResMac Inc. REZYFi Lending primarily addresses emerging real estate-related financing opportunities. ResMac is the company’s traditional mortgage origination, correspondent and servicing operation. As a whole, REZYFi is using its corporate strengths as a foundation for diversifying its approach to capitalize on growth in multiple verticals in the years to come.”

To view the full article, visit https://cnw.fm/UhfGv

About REZYFi Inc.

REZYFi is a cannabis-focused mortgage origination and specialized financing company in the U.S. The company originates, structures and invests in first mortgage loans and alternative structured financings secured by commercial and residential real estate properties. For more information, visit the company’s website at REZYFi.com.

NOTE TO INVESTORS: The latest news and updates relating to REZYFi are available in the company’s newsroom at https://cnw.fm/REZY

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.cannabisnewswire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

• Miami-based REZYFi is a mortgage lender working with traditional loans but focusing particular attention on unbanked market sectors such as the cannabis industry and those property companies that provide leases to those sectors
• The loan origination industry appears to be experiencing a new round of greening in reversal of the year’s difficulties
• In the wake of positive CPI data last month, analysts are beginning to anticipate a greening of mortgage lending rates once inflationary pressures are reduced, making it easier for companies to obtain loans for their projects

The greening of inflation news last month is important news for market watchers, and expectations that the Consumer Price Index (“CPI”) will continue to report favorable inflation trends has mortgage lenders anticipating less pressure on rates during the coming year and beyond.

“We’re expecting the Fed to end its Fed Funds increases into the beginning of next year, so we are expecting mortgage rates to come down to 5.4% by the end of next year and then to come further down to 4.5% by the end of 2024,” Mortgage Bankers Association Associate Vice President of Housing Economics Edward Seiler told WTOP news, referring to the average rate on a 30-year fixed-rate mortgage (https://cnw.fm/F5czL).

The CPI report that is anticipated on Dec. 13 and the Fed’s policy decision announcement the following day will tell the tale about whether the government thinks its efforts over the past several months have had the desired effect in curbing inflation and in setting the stage for lower long-term rates. Analysts are already suggesting that, even with another raise in interest rates, it could be small enough to signal an important topping out and reversal of the previous trend (https://cnw.fm/YbdlD). As mortgage rates gradually fall as expected, it reopens the door for companies that have struggled to pursue their projects in recent months.

Specialized financing company REZYFi is a growing mortgage lender working to help such businesses navigate the challenging landscape of loan origination, particularly as it applies to the traditionally underserved cannabis industry and property owners who lease to such companies.

REZYFi is anticipating the launch of its high-margin cannabis division in the coming weeks to focus on such challenging lending markets. The company also is developing a proprietary technology that will help it operate competitively by maintaining efficient turnaround time while also being economical with staffing levels.

Through its subsidiaries, REZYFi Lending and ResMac Inc., the company has closed over 20,000 loans for over 15,000 clients and expects to originate $285 million retail sales during the coming year, with $250 million in wholesale origination in motion.

Now operating in 30 states, the company expects to expand to all 50 states in the process of fulfilling its growth goals.

For more information, visit the company’s website at www.REZYFi.com. 

NOTE TO INVESTORS: The latest news and updates relating to REZYFi are available in the company’s newsroom at https://cnw.fm/REZY

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.cannabisnewswire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

U.S. President Joe Biden made history when he enacted the cannabis research bill and signed it into law on Nov. 2, 2022. The law now waits for 60 days for the attorney general to either approve it or ask for supplementary information from the originator of the bill. This new law opens the gates for further extensive research on marijuana to be done.

The use of cannabis is prohibited federally in the United States except for FDA-approved research. Specific states have, however, enacted legislation permitting the plant or its derivatives for research, medical, industrial and or recreational purposes.

President Biden still stands opposed to the legalization of cannabis. However, he has campaigned on several platforms for reforms of marijuana, including promoting research, decriminalization, more modest reforms to marijuana laws and rescheduling cannabis under the Controlled Substances Act (CSA).  This also comes hot on the heels of a mass pardon for Americans who have been convicted for being in possession of cannabis. This clemency has been viewed by the White House as one of the top accomplishments of the president.

For some years, the federal government has blocked the way of science due to stringent conditions researchers have to meet before being cleared to begin studying cannabis. But after years of lobbying and negotiations, the bill has finally been enacted, said Senator Dianne Feinstein in a tweet. Feinstein is hopeful that this will open up rigorous and critical research that will enable medical personnel to help millions of people needing drugs derived from cannabis.

The medical fraternity agrees that there is a need for more extensive research to be done in order to learn cannabis’ health benefits and give the masses other treatment options. This law removes barriers that had previously inhibited researchers.

Notably, the law does not provide a free pass for the researchers to access cannabis from state-approved or state-owned dispensaries for research purposes. The law has also encouraged the Food and Drug Administration (FDA) to develop cannabis-derived drugs while the Drug Enforcement Administration has to approve applications from manufacturers of drugs derived from marijuana and the same drugs are FDA-approved under the bill. Manufacturers also get a reprieve as the law allows for the importation of cannabis derivatives and materials to facilitate research.

The DEA in recent years has approved new marijuana cultivators for the purposes of studies while the National Institute on Drug Abuse published a solicitation for applications for authorized growers as it looks for contractors to supply the agency with cannabis for the purposes of research.

The Department of Health and Human Services is keen on learning about the health benefits versus the risks of cannabis. And, as more people take up the home cultivation of medical marijuana, entities that focus on making indoor cultivation equipment, such as Advanced Container Technologies Inc. (OTC: ACTX), are likely to expand their footprint across the nation.

NOTE TO INVESTORS: The latest news and updates relating to Advanced Container Technologies Inc. (OTC: ACTX) are available in the company’s newsroom at https://cnw.fm/ACTX

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

More than two decades after California first legalized medical cannabis, dozens of states now have their own medical and recreational cannabis markets. The cannabis industry generates billions of dollars in sales every year, proving that cannabis is one of the most popular drugs in the country even as states have loosened their policies.

However, the federal government still considers cannabis a Schedule I controlled substance, meaning that even though qualifying individuals are allowed to take part in state-legal cannabis markets, their actions remain illegal at the federal level.

As a result, cannabis consumers often find themselves penalized for purchasing and consuming cannabis even though it is legal in their states. For instance, federal employees who are subject to regular drug tests may be penalized for consuming cannabis in accordance with state law.

Reform activists and some lawmakers have long argued against federal prohibition for this and other reasons, stating that federal cannabis policies simply don’t reflect what is happening on the ground.

Last week, the Office of Personnel Management announced that it was proposing to treat past cannabis use more leniently during job applications. The federal agency is proposing to revise job applications such that they only ask applicants if they consumed cannabis within the past 90 days rather than at any point in history. However, applicants for public safety, national security or criminal justice positions would be asked if they have consumed cannabis at any time prior to their application.

The changes will be open to public comment for a two-month period and will result in a more lenient application process for federal employees if they are codified. If the changes receive approval, the draft Vetting Questionnaire would replace the current SF86, SF85, SF 85P-S and SF85P forms.

These forms typically cover positions with varying sensitivity and security levels, and they require applicants to divulge any illicit drug use by checking boxes. Even though cannabis is legal for adult consumption in more than 20 states and medical use in more than 30 states, it is still illicit at the federal level.

With the proposed changes in place, applicants will be provided with a much narrower timeline for past cannabis use. Furthermore, they will not be required to disclose the use of cannabis products with less than 0.3% THC, which is the main psychoactive agent in marijuana.

Answering yes to whether they used cannabis within the past 90 days would prompt additional questions, especially for individuals who were previously employed in a public safety, criminal justice or national security position.

As the restrictions surrounding marijuana gradually ease, entities such as REZYFi Inc., which are focused on funding cannabis companies, are likely to serve a wider market as more players enter the space and find traditional funding sources inadequate for their needs.

NOTE TO INVESTORS: The latest news and updates relating to REZYFi Inc. are available in the company’s newsroom at https://cnw.fm/REZY

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

Cigarette smoking in the United States has been on a decline since 1964 when adult smoking prevalence rates peaked. As the population has become more cognizant of the health risks of smoking, fewer young people have picked up the habit. By 2020, only 13 out of every 100 adults in America (12.5%) smoked regularly.

A new report from Gallup has now revealed that young Americans are two times more likely to report smoking cannabis compared to tobacco cigarettes. Gallup analyzed survey data on marijuana and tobacco use among adults from 2001 to 2022, finding that past-week tobacco use by adults aged 18–29 has gone down from 15% in 2016 through 2018 to 12% in 2019 through 2022.

Interestingly, there was an increase in cannabis use during this period, with 26% of adults in the 18– to 29–year-old age group reporting that they smoke cannabis in 2019 to 2022 compared to 21% of adults in 2016 to 2018. The preference for cannabis in favor of tobacco was strongest among the youngest generation of adults. This is likely due to a variety of factors, such as increased public campaigns on the dangers of tobacco as well as a change in perception of the purported harms of cannabis.

Furthermore, there is also a chance that people are more comfortable reporting cannabis use amid countrywide drug reform efforts that have seen dozens of states legalize cannabis and lawmakers table legislation to legalize cannabis at the federal level.

Although around 40% of adults in the 18- to 29-year-old age group were more likely to vape or smoke something, 11% reported smoking only cannabis compared to 3% who only smoked tobacco. On the other hand, adults in the 30- to 49-year-old age group were more likely to report smoking only cigarettes in the past week (11%) compared to those who smoked only cannabis within the past week (8%).

This latest poll adds to the growing body of research showing that tobacco use is experiencing a steady decline while cannabis use is becoming more preferable to young adults.

A different poll released by Gallup in August was the first-ever survey where more Americans openly admitted to consuming cannabis in the past week compared to those who reported smoking cigarettes.

Another Gallup poll from 2019 revealed that young people are more likely to smoke cannabis than cigarettes. The poll found that cigarette consumption was at a 75-year low at 15% while cannabis use had remained relatively stable for the previous four years at 12%.

As more entities enter the cannabis space to serve the growing number of consumers, companies such as REZYFi Inc., which provide funding to marijuana companies, are likely to see surging demand for their services.

NOTE TO INVESTORS: The latest news and updates relating to REZYFi, Inc. are available in the company’s newsroom at https://cnw.fm/REZY

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.